ARCHIVES

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

Nutrition, Disease Oriented Contracts

December 4, 1981

Large, Conclusive Trials Provide Answers To Treatment Questions For GI Cancers

June 26, 2009

Army Breast Cancer Program Seeks Grants Applicants

May 17, 1996

“Dollars For Docs” Database Of Pharma Payments Posted By News Organization

October 22, 2010

Cancer Rates May Rise 50% By 2020, IARC Says

April 18, 2003

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014